Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy

The mechanisms through which aberrant alpha-synuclein (ASYN) leads to neuronal death in Parkinson's disease (PD) are uncertain. In isolated liver lysosomes, mutant ASYNs impair Chaperone Mediated Autophagy (CMA), a targeted lysosomal degradation pathway; however, whether this occurs in a cellul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2009-05, Vol.4 (5), p.e5515
Hauptverfasser: Xilouri, Maria, Vogiatzi, Tereza, Vekrellis, Kostas, Park, David, Stefanis, Leonidas
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 5
container_start_page e5515
container_title PloS one
container_volume 4
creator Xilouri, Maria
Vogiatzi, Tereza
Vekrellis, Kostas
Park, David
Stefanis, Leonidas
description The mechanisms through which aberrant alpha-synuclein (ASYN) leads to neuronal death in Parkinson's disease (PD) are uncertain. In isolated liver lysosomes, mutant ASYNs impair Chaperone Mediated Autophagy (CMA), a targeted lysosomal degradation pathway; however, whether this occurs in a cellular context, and whether it mediates ASYN toxicity, is unknown. We have investigated presently the effects of WT or mutant ASYN on the lysosomal pathways of CMA and macroautophagy in neuronal cells and assessed their impact on ASYN-mediated toxicity. Novel inducible SH-SY5Y and PC12 cell lines expressing human WT and A53T ASYN, as well as two mutant forms that lack the CMA-targeting motif were generated. Such forms were also expressed in primary cortical neurons, using adenoviral transduction. In each case, effects on long-lived protein degradation, LC3 II levels (as a macroautophagy index), and cell death and survival were assessed. In both PC12 and SH-SY5Y cycling cells, induction of A53T ASYN evoked a significant decrease in lysosomal degradation, largely due to CMA impairment. In neuronally differentiated SH-SH5Y cells, both WT and A53T ASYN induction resulted in gradual toxicity, which was partly dependent on CMA impairment and compensatory macroautophagy induction. In primary neurons both WT and A53T ASYN were toxic, but only in the case of A53T ASYN did CMA dysfunction and compensatory macroautophagy induction occur and participate in death. Expression of mutant A53T, and, in some cases, WT ASYN in neuronal cells leads to CMA dysfunction, and this in turn leads to compensatory induction of macroautophagy. Inhibition of these lysosomal effects mitigates ASYN toxicity. Therefore, CMA dysfunction mediates aberrant ASYN toxicity, and may be a target for therapeutic intervention in PD and related disorders. Furthermore, macroautophagy induction in the context of ASYN over-expression, in contrast to other settings, appears to be a detrimental response, leading to neuronal death.
doi_str_mv 10.1371/journal.pone.0005515
format Article
fullrecord <record><control><sourceid>proquest_plos_</sourceid><recordid>TN_cdi_plos_journals_1291062898</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c3282bbc142448beace79a2d97c3ae51</doaj_id><sourcerecordid>2897535221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c524t-43d336a0b61a0aa864b7a27473d5cbd1be8f6433bb39ef2a575686718761bcc33</originalsourceid><addsrcrecordid>eNp1Uk1v1DAQtRCIlsI_QGCJc5b4I7ZzQaoqPipV4gJna-w4G69SO9gO6v57XDZAe-Dk8cybN_NGD6HXpN0RJsn7Q1xTgHm3xOB2bdt2HemeoHPSM9oI2rKnD-Iz9CLnQ8UwJcRzdEZ6zoTsxDmKl8a4BKFgmJcJmnwMq52dD9jGMLqUcYl33vpyrAEObk0xZFzLC6SCy5Tiup_qf_LGFx8DjiO2Eyyu4lxz6wYPxQ0Y1hIr_f74Ej0bYc7u1fZeoO-fPn67-tLcfP18fXV509iO8tJwNjAmoDWCQAugBDcSqOSSDZ01AzFOjYIzZgzr3Uihq2KUkERJQYy1jF2gtyfeZY5Zb7fKmtCetIKqXlXE9QkxRDjoJflbSEcdwevfiZj2ukr09RjaMqqoMZZwyrkyDqyTPdChl5aB60jl-rBNW03VbF0oCeZHpI8rwU96H39qKqSUrKsE7zaCFH-sLpf_rMxPKJtizsmNfyeQVt-b4k-XvjeF3kxR29483O5f0-YC9gvu47iB</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1291062898</pqid></control><display><type>article</type><title>Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Xilouri, Maria ; Vogiatzi, Tereza ; Vekrellis, Kostas ; Park, David ; Stefanis, Leonidas</creator><contributor>Gendelman, Howard E.</contributor><creatorcontrib>Xilouri, Maria ; Vogiatzi, Tereza ; Vekrellis, Kostas ; Park, David ; Stefanis, Leonidas ; Gendelman, Howard E.</creatorcontrib><description>The mechanisms through which aberrant alpha-synuclein (ASYN) leads to neuronal death in Parkinson's disease (PD) are uncertain. In isolated liver lysosomes, mutant ASYNs impair Chaperone Mediated Autophagy (CMA), a targeted lysosomal degradation pathway; however, whether this occurs in a cellular context, and whether it mediates ASYN toxicity, is unknown. We have investigated presently the effects of WT or mutant ASYN on the lysosomal pathways of CMA and macroautophagy in neuronal cells and assessed their impact on ASYN-mediated toxicity. Novel inducible SH-SY5Y and PC12 cell lines expressing human WT and A53T ASYN, as well as two mutant forms that lack the CMA-targeting motif were generated. Such forms were also expressed in primary cortical neurons, using adenoviral transduction. In each case, effects on long-lived protein degradation, LC3 II levels (as a macroautophagy index), and cell death and survival were assessed. In both PC12 and SH-SY5Y cycling cells, induction of A53T ASYN evoked a significant decrease in lysosomal degradation, largely due to CMA impairment. In neuronally differentiated SH-SH5Y cells, both WT and A53T ASYN induction resulted in gradual toxicity, which was partly dependent on CMA impairment and compensatory macroautophagy induction. In primary neurons both WT and A53T ASYN were toxic, but only in the case of A53T ASYN did CMA dysfunction and compensatory macroautophagy induction occur and participate in death. Expression of mutant A53T, and, in some cases, WT ASYN in neuronal cells leads to CMA dysfunction, and this in turn leads to compensatory induction of macroautophagy. Inhibition of these lysosomal effects mitigates ASYN toxicity. Therefore, CMA dysfunction mediates aberrant ASYN toxicity, and may be a target for therapeutic intervention in PD and related disorders. Furthermore, macroautophagy induction in the context of ASYN over-expression, in contrast to other settings, appears to be a detrimental response, leading to neuronal death.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0005515</identifier><identifier>PMID: 19436756</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Aberration ; Acidification ; Adenoviruses ; alpha-Synuclein - genetics ; alpha-Synuclein - metabolism ; alpha-Synuclein - toxicity ; Animals ; Apoptosis ; Autophagy ; Biodegradation ; Biomedical research ; Cell death ; Cell Line ; Cell lines ; Cell survival ; Degradation ; Disease ; Down-Regulation ; Humans ; Hypotheses ; Impairment ; Inhibition ; Liver ; Lysosomes ; Lysosomes - metabolism ; Molecular Chaperones - metabolism ; Mortality ; Movement disorders ; Mutation ; Neurodegenerative diseases ; Neurological Disorders ; Neurological Disorders/Movement Disorders ; Neurons ; Neurons - metabolism ; Neuroscience ; Neuroscience/Neurobiology of Disease and Regeneration ; Neurosciences ; Neurotoxicity ; Overexpression ; Parkinson Disease - metabolism ; Parkinson's disease ; PC12 Cells ; Phagocytosis ; Pheochromocytoma cells ; Proteins ; Rats ; RNA, Small Interfering - metabolism ; Rodents ; Synuclein ; Toxicity ; Trends</subject><ispartof>PloS one, 2009-05, Vol.4 (5), p.e5515</ispartof><rights>2009 Xilouri et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Xilouri et al. 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c524t-43d336a0b61a0aa864b7a27473d5cbd1be8f6433bb39ef2a575686718761bcc33</citedby><cites>FETCH-LOGICAL-c524t-43d336a0b61a0aa864b7a27473d5cbd1be8f6433bb39ef2a575686718761bcc33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2677735/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2677735/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,2103,2929,23871,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19436756$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Gendelman, Howard E.</contributor><creatorcontrib>Xilouri, Maria</creatorcontrib><creatorcontrib>Vogiatzi, Tereza</creatorcontrib><creatorcontrib>Vekrellis, Kostas</creatorcontrib><creatorcontrib>Park, David</creatorcontrib><creatorcontrib>Stefanis, Leonidas</creatorcontrib><title>Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>The mechanisms through which aberrant alpha-synuclein (ASYN) leads to neuronal death in Parkinson's disease (PD) are uncertain. In isolated liver lysosomes, mutant ASYNs impair Chaperone Mediated Autophagy (CMA), a targeted lysosomal degradation pathway; however, whether this occurs in a cellular context, and whether it mediates ASYN toxicity, is unknown. We have investigated presently the effects of WT or mutant ASYN on the lysosomal pathways of CMA and macroautophagy in neuronal cells and assessed their impact on ASYN-mediated toxicity. Novel inducible SH-SY5Y and PC12 cell lines expressing human WT and A53T ASYN, as well as two mutant forms that lack the CMA-targeting motif were generated. Such forms were also expressed in primary cortical neurons, using adenoviral transduction. In each case, effects on long-lived protein degradation, LC3 II levels (as a macroautophagy index), and cell death and survival were assessed. In both PC12 and SH-SY5Y cycling cells, induction of A53T ASYN evoked a significant decrease in lysosomal degradation, largely due to CMA impairment. In neuronally differentiated SH-SH5Y cells, both WT and A53T ASYN induction resulted in gradual toxicity, which was partly dependent on CMA impairment and compensatory macroautophagy induction. In primary neurons both WT and A53T ASYN were toxic, but only in the case of A53T ASYN did CMA dysfunction and compensatory macroautophagy induction occur and participate in death. Expression of mutant A53T, and, in some cases, WT ASYN in neuronal cells leads to CMA dysfunction, and this in turn leads to compensatory induction of macroautophagy. Inhibition of these lysosomal effects mitigates ASYN toxicity. Therefore, CMA dysfunction mediates aberrant ASYN toxicity, and may be a target for therapeutic intervention in PD and related disorders. Furthermore, macroautophagy induction in the context of ASYN over-expression, in contrast to other settings, appears to be a detrimental response, leading to neuronal death.</description><subject>Aberration</subject><subject>Acidification</subject><subject>Adenoviruses</subject><subject>alpha-Synuclein - genetics</subject><subject>alpha-Synuclein - metabolism</subject><subject>alpha-Synuclein - toxicity</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Autophagy</subject><subject>Biodegradation</subject><subject>Biomedical research</subject><subject>Cell death</subject><subject>Cell Line</subject><subject>Cell lines</subject><subject>Cell survival</subject><subject>Degradation</subject><subject>Disease</subject><subject>Down-Regulation</subject><subject>Humans</subject><subject>Hypotheses</subject><subject>Impairment</subject><subject>Inhibition</subject><subject>Liver</subject><subject>Lysosomes</subject><subject>Lysosomes - metabolism</subject><subject>Molecular Chaperones - metabolism</subject><subject>Mortality</subject><subject>Movement disorders</subject><subject>Mutation</subject><subject>Neurodegenerative diseases</subject><subject>Neurological Disorders</subject><subject>Neurological Disorders/Movement Disorders</subject><subject>Neurons</subject><subject>Neurons - metabolism</subject><subject>Neuroscience</subject><subject>Neuroscience/Neurobiology of Disease and Regeneration</subject><subject>Neurosciences</subject><subject>Neurotoxicity</subject><subject>Overexpression</subject><subject>Parkinson Disease - metabolism</subject><subject>Parkinson's disease</subject><subject>PC12 Cells</subject><subject>Phagocytosis</subject><subject>Pheochromocytoma cells</subject><subject>Proteins</subject><subject>Rats</subject><subject>RNA, Small Interfering - metabolism</subject><subject>Rodents</subject><subject>Synuclein</subject><subject>Toxicity</subject><subject>Trends</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNp1Uk1v1DAQtRCIlsI_QGCJc5b4I7ZzQaoqPipV4gJna-w4G69SO9gO6v57XDZAe-Dk8cybN_NGD6HXpN0RJsn7Q1xTgHm3xOB2bdt2HemeoHPSM9oI2rKnD-Iz9CLnQ8UwJcRzdEZ6zoTsxDmKl8a4BKFgmJcJmnwMq52dD9jGMLqUcYl33vpyrAEObk0xZFzLC6SCy5Tiup_qf_LGFx8DjiO2Eyyu4lxz6wYPxQ0Y1hIr_f74Ej0bYc7u1fZeoO-fPn67-tLcfP18fXV509iO8tJwNjAmoDWCQAugBDcSqOSSDZ01AzFOjYIzZgzr3Uihq2KUkERJQYy1jF2gtyfeZY5Zb7fKmtCetIKqXlXE9QkxRDjoJflbSEcdwevfiZj2ukr09RjaMqqoMZZwyrkyDqyTPdChl5aB60jl-rBNW03VbF0oCeZHpI8rwU96H39qKqSUrKsE7zaCFH-sLpf_rMxPKJtizsmNfyeQVt-b4k-XvjeF3kxR29483O5f0-YC9gvu47iB</recordid><startdate>20090513</startdate><enddate>20090513</enddate><creator>Xilouri, Maria</creator><creator>Vogiatzi, Tereza</creator><creator>Vekrellis, Kostas</creator><creator>Park, David</creator><creator>Stefanis, Leonidas</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20090513</creationdate><title>Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy</title><author>Xilouri, Maria ; Vogiatzi, Tereza ; Vekrellis, Kostas ; Park, David ; Stefanis, Leonidas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c524t-43d336a0b61a0aa864b7a27473d5cbd1be8f6433bb39ef2a575686718761bcc33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Aberration</topic><topic>Acidification</topic><topic>Adenoviruses</topic><topic>alpha-Synuclein - genetics</topic><topic>alpha-Synuclein - metabolism</topic><topic>alpha-Synuclein - toxicity</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Autophagy</topic><topic>Biodegradation</topic><topic>Biomedical research</topic><topic>Cell death</topic><topic>Cell Line</topic><topic>Cell lines</topic><topic>Cell survival</topic><topic>Degradation</topic><topic>Disease</topic><topic>Down-Regulation</topic><topic>Humans</topic><topic>Hypotheses</topic><topic>Impairment</topic><topic>Inhibition</topic><topic>Liver</topic><topic>Lysosomes</topic><topic>Lysosomes - metabolism</topic><topic>Molecular Chaperones - metabolism</topic><topic>Mortality</topic><topic>Movement disorders</topic><topic>Mutation</topic><topic>Neurodegenerative diseases</topic><topic>Neurological Disorders</topic><topic>Neurological Disorders/Movement Disorders</topic><topic>Neurons</topic><topic>Neurons - metabolism</topic><topic>Neuroscience</topic><topic>Neuroscience/Neurobiology of Disease and Regeneration</topic><topic>Neurosciences</topic><topic>Neurotoxicity</topic><topic>Overexpression</topic><topic>Parkinson Disease - metabolism</topic><topic>Parkinson's disease</topic><topic>PC12 Cells</topic><topic>Phagocytosis</topic><topic>Pheochromocytoma cells</topic><topic>Proteins</topic><topic>Rats</topic><topic>RNA, Small Interfering - metabolism</topic><topic>Rodents</topic><topic>Synuclein</topic><topic>Toxicity</topic><topic>Trends</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xilouri, Maria</creatorcontrib><creatorcontrib>Vogiatzi, Tereza</creatorcontrib><creatorcontrib>Vekrellis, Kostas</creatorcontrib><creatorcontrib>Park, David</creatorcontrib><creatorcontrib>Stefanis, Leonidas</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection (ProQuest)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xilouri, Maria</au><au>Vogiatzi, Tereza</au><au>Vekrellis, Kostas</au><au>Park, David</au><au>Stefanis, Leonidas</au><au>Gendelman, Howard E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2009-05-13</date><risdate>2009</risdate><volume>4</volume><issue>5</issue><spage>e5515</spage><pages>e5515-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>The mechanisms through which aberrant alpha-synuclein (ASYN) leads to neuronal death in Parkinson's disease (PD) are uncertain. In isolated liver lysosomes, mutant ASYNs impair Chaperone Mediated Autophagy (CMA), a targeted lysosomal degradation pathway; however, whether this occurs in a cellular context, and whether it mediates ASYN toxicity, is unknown. We have investigated presently the effects of WT or mutant ASYN on the lysosomal pathways of CMA and macroautophagy in neuronal cells and assessed their impact on ASYN-mediated toxicity. Novel inducible SH-SY5Y and PC12 cell lines expressing human WT and A53T ASYN, as well as two mutant forms that lack the CMA-targeting motif were generated. Such forms were also expressed in primary cortical neurons, using adenoviral transduction. In each case, effects on long-lived protein degradation, LC3 II levels (as a macroautophagy index), and cell death and survival were assessed. In both PC12 and SH-SY5Y cycling cells, induction of A53T ASYN evoked a significant decrease in lysosomal degradation, largely due to CMA impairment. In neuronally differentiated SH-SH5Y cells, both WT and A53T ASYN induction resulted in gradual toxicity, which was partly dependent on CMA impairment and compensatory macroautophagy induction. In primary neurons both WT and A53T ASYN were toxic, but only in the case of A53T ASYN did CMA dysfunction and compensatory macroautophagy induction occur and participate in death. Expression of mutant A53T, and, in some cases, WT ASYN in neuronal cells leads to CMA dysfunction, and this in turn leads to compensatory induction of macroautophagy. Inhibition of these lysosomal effects mitigates ASYN toxicity. Therefore, CMA dysfunction mediates aberrant ASYN toxicity, and may be a target for therapeutic intervention in PD and related disorders. Furthermore, macroautophagy induction in the context of ASYN over-expression, in contrast to other settings, appears to be a detrimental response, leading to neuronal death.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>19436756</pmid><doi>10.1371/journal.pone.0005515</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2009-05, Vol.4 (5), p.e5515
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1291062898
source MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Aberration
Acidification
Adenoviruses
alpha-Synuclein - genetics
alpha-Synuclein - metabolism
alpha-Synuclein - toxicity
Animals
Apoptosis
Autophagy
Biodegradation
Biomedical research
Cell death
Cell Line
Cell lines
Cell survival
Degradation
Disease
Down-Regulation
Humans
Hypotheses
Impairment
Inhibition
Liver
Lysosomes
Lysosomes - metabolism
Molecular Chaperones - metabolism
Mortality
Movement disorders
Mutation
Neurodegenerative diseases
Neurological Disorders
Neurological Disorders/Movement Disorders
Neurons
Neurons - metabolism
Neuroscience
Neuroscience/Neurobiology of Disease and Regeneration
Neurosciences
Neurotoxicity
Overexpression
Parkinson Disease - metabolism
Parkinson's disease
PC12 Cells
Phagocytosis
Pheochromocytoma cells
Proteins
Rats
RNA, Small Interfering - metabolism
Rodents
Synuclein
Toxicity
Trends
title Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T15%3A40%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Abberant%20alpha-synuclein%20confers%20toxicity%20to%20neurons%20in%20part%20through%20inhibition%20of%20chaperone-mediated%20autophagy&rft.jtitle=PloS%20one&rft.au=Xilouri,%20Maria&rft.date=2009-05-13&rft.volume=4&rft.issue=5&rft.spage=e5515&rft.pages=e5515-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0005515&rft_dat=%3Cproquest_plos_%3E2897535221%3C/proquest_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1291062898&rft_id=info:pmid/19436756&rft_doaj_id=oai_doaj_org_article_c3282bbc142448beace79a2d97c3ae51&rfr_iscdi=true